Capital International Investors Boosts Stock Holdings in Ascendis Pharma A/S (NASDAQ:ASND)

Capital International Investors boosted its stake in shares of Ascendis Pharma A/S (NASDAQ:ASND – Free Report) by 0.3% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,995,271 shares of the biotechnology company’s stock after purchasing an additional 6,165 shares during the […]

Leave a Reply

Your email address will not be published.

Previous post Guggenheim Capital LLC Acquires 11,463 Shares of iShares MBS ETF (NASDAQ:MBB)
Next post Capital International Investors Has $167.90 Million Position in Centene Co. (NYSE:CNC)